This refresh
Data-driven refresh May 20, 2026. Top 5 per bucket by live Bull Rankings score across a 5177-ticker universe covering every US-listed common stock on NYSE, NASDAQ, NYSE American, and NYSE Arca (2504 passed the market-cap / liquidity screen). Fundamentals sourced from Yahoo Finance quoteSummary + quarterly FCF reconstruction; narrative from Gemini (with data-driven fallback). Intraday re-ranking from a top-30 per-bucket shortlist.
Growth — high-quality compounders
1. KGC — Kinross Gold Corporation · score 99
Gold · price $27.44 · 1Y $41.23 · 5Y $44.19 · 10Y $64.96
FCF $3.0b B · Rev +60.8% A · D/E 0.08 A · P/E 11.7x A- · PEG 1.12 B+
Why now. Kinross Gold Corporation, a leading gold producer, is poised for growth driven by its strong revenue growth rate of 60.8% and a 36% profit margin. With a current price of $27.44 and a P/E of 11.7, the company's valuation is reasonable considering its growth prospects. The analyst consensus 1-yr target of $41.23 suggests a potential upside, supported by the company's ability to generate significant free cash flow.
Moat. Kinross Gold Corporation's durable competitive advantage stems from its high return on equity of 35.5%, which is driven by its pricing power in the gold market. The company's low debt-to-equity ratio of 0.08 and significant free cash flow of $3.03 billion also contribute to its moat. Additionally, the company's ability to maintain a high profit margin in a competitive industry is a testament to its strong market position.
Risk. The main risks facing Kinross Gold Corporation include its high beta of 1.37, which makes it more volatile than the overall market, and the potential for fluctuations in gold prices. The company is also exposed to regulatory risks, particularly in jurisdictions where it operates, such as changes in mining regulations or environmental laws. Furthermore, the company's reliance on a few key assets and its limited geographic diversification increase its operational risk.
Horizon. 1-3 yr $41.23 (analyst consensus (n=11)) — fundamentals + valuation re-rating. 5 yr $44.19 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $64.96 if current growth sustains into durable earnings power.
2. FSM — Fortuna Mining Corp. · score 96
Gold · price $9.13 · 1Y $10.50 · 5Y $14.70 · 10Y $21.61
FCF $563m C+ · Rev +75.6% A · D/E 0.11 A- · P/E 8.5x A- · PEG n/a
Why now. Fortuna Mining Corp., a gold mining company, is currently trading at $9.13 with a PE ratio of 8.5, indicating undervaluation. The company has demonstrated a revenue growth rate of 75.6% and a profit margin of 31.1%, driven by its high-quality gold mining operations. With an analyst consensus target of $14, there is potential for significant upside.
Moat. Fortuna Mining Corp.'s durable competitive advantage stems from its 22% ROE, which is driven by its pricing power in the gold mining industry. The company's high-quality gold deposits and efficient mining operations enable it to maintain a cost advantage, resulting in strong profitability. Additionally, the company's low debt-to-equity ratio of 0.11 provides financial flexibility and reduces the risk of default.
Risk. The company faces risks from volatility in gold prices, which can impact revenue and profitability. Additionally, the company's high beta of 2.09 indicates that its stock price is highly sensitive to market fluctuations. Furthermore, the company's reliance on a single analyst consensus target may not accurately reflect the company's true value, posing a risk to investors.
Horizon. 1-3 yr $10.50 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $14.70 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $21.61 if current growth sustains into durable earnings power.
3. PICS — PicS N.V. · score 96
Software - Infrastructure · price $10.96 · 1Y $22.27 · 5Y $17.65 · 10Y $25.95
FCF $168m C · Rev +68.7% A · D/E 0.41 B+ · P/E 6.6x A · PEG n/a
Why now. PicS N.V., a software infrastructure company, is currently trading at a $10.96 price point with a 6.6 P/E ratio, indicating undervaluation. The company has demonstrated a 68.7% revenue growth rate over the past year, driven by its growth strategy. With an analyst consensus 1-yr target of $22.27, there is potential for significant upside.
Moat. PicS N.V. has a durable competitive advantage driven by its high 40.4% ROE, which is attributed to its pricing power and category leadership in the software infrastructure market. The company's 10.6% profit margin and $167.97M in free cash flow also contribute to its competitive advantage, allowing it to invest in growth initiatives and maintain its market position.
Risk. One of the key risks facing PicS N.V. is its 0.41 debt-to-equity ratio, which may limit its ability to take on additional debt to finance growth initiatives. Additionally, the company's reliance on a few key customers and the potential for regulatory changes in the software infrastructure market also pose risks. Competitors such as Microsoft and Amazon may also pose a threat to PicS N.V.'s market share.
Horizon. 1-3 yr $22.27 (analyst consensus (n=9)) — fundamentals + valuation re-rating. 5 yr $17.65 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $25.95 if current growth sustains into durable earnings power.
4. DLO — DLocal Limited · score 95
Software - Infrastructure · price $11.84 · 1Y $17.65 · 5Y $19.07 · 10Y $28.03
FCF $374m C · Rev +54.9% A · D/E 0.20 A- · P/E 18.5x B · PEG n/a
Why now. DLocal Limited, a leading provider of payment processing solutions to emerging markets, is currently trading at a $11.84 price point with a 18.5 P/E ratio, indicating a reasonable valuation for its 54.9% revenue growth rate. The company's 15.8% profit margin and 35% ROE demonstrate its ability to generate strong earnings, driven by its growing presence in high-growth markets. With an analyst consensus 1-yr target of $17.65, the stock has potential for near-term upside.
Moat. DLocal's durable competitive advantage stems from its expertise in navigating complex payment infrastructures in emerging markets, allowing it to capture a significant share of the growing digital payments market. The company's 35% ROE can be attributed to its pricing power, driven by its category leadership in providing payment solutions to merchants operating in these markets. Additionally, DLocal's low 0.2 debt-to-equity ratio provides it with the financial flexibility to invest in growth initiatives and further solidify its market position.
Risk. Key risks for DLocal include competition from established payment processors, such as PayPal and Stripe, which could potentially disrupt its growth trajectory. Additionally, the company's 1.02 beta indicates a relatively high level of market sensitivity, making it vulnerable to broader market fluctuations. Regulatory risks, particularly in emerging markets, also pose a threat to DLocal's operations, as changes in payment regulations could impact its ability to operate effectively.
Horizon. 1-3 yr $17.65 (analyst consensus (n=10)) — fundamentals + valuation re-rating. 5 yr $19.07 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $28.03 if current growth sustains into durable earnings power.
5. EXE — Expand Energy Corporation · score 93
Oil & Gas E&P · price $100.89 · 1Y $132.12 · 5Y $162.48 · 10Y $238.84
FCF $2.8b B · Rev +41.0% A · D/E 0.26 A- · P/E 7.5x A · PEG 22.90 D
Why now. Expand Energy Corporation, an Oil & Gas E&P company, is currently trading at a $100.89 price point with a 7.5 P/E ratio, indicating a relatively low valuation. The company has demonstrated a 41% revenue growth rate over the past year, driven by its strong presence in the energy market. With an analyst consensus 1-yr target of $132.12, there is potential for significant upside.
Moat. Expand Energy Corporation's durable competitive advantage stems from its high 17.6% ROE, which is attributed to its pricing power in the energy market. The company's 24.9% profit margin and $2.8B in free cash flow also contribute to its strong financial position. Additionally, its low 0.26 debt-to-equity ratio provides a stable foundation for future growth.
Risk. One of the primary risks facing Expand Energy Corporation is the potential for decreased demand in the energy market, which could negatively impact revenue growth. The company's 0.35 beta also indicates a relatively low level of volatility, but this could change if the energy market experiences significant fluctuations. Furthermore, the 22.9 PEG ratio suggests that the stock may be overvalued relative to its growth rate.
Horizon. 1-3 yr $132.12 (analyst consensus (n=25)) — fundamentals + valuation re-rating. 5 yr $162.48 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $238.84 if current growth sustains into durable earnings power.
Value — quality at a discount
1. PDD — PDD Holdings Inc. · score 102
Internet Retail · price $97.34 · 1Y $142.85 · 5Y $130.26 · 10Y $166.27
FCF $15.6b A- · Rev +12.0% B+ · D/E 0.01 A · P/E 10.0x A- · PEG 0.68 A-
Why now. PDD Holdings Inc., a leading e-commerce platform, is undervalued given its 12% revenue growth rate and 22.7% profit margin. With a current price of $97.34 and a 10 P/E ratio, the company's free cash flow of $15.55B is attractive. The analyst consensus 1-yr target of $142.85 suggests a potential re-rating catalyst.
Moat. PDD's durable competitive advantage stems from its 26.9% ROE, driven by pricing power from category leadership in e-commerce. The company's low debt-to-equity ratio of 0.01 and high profit margin also contribute to its strong financial position. Additionally, PDD's large market cap of $138.55B and dominant market share provide a significant barrier to entry for competitors.
Risk. PDD faces risks from competitors such as Alibaba and JD.com, as well as regulatory risks from the Chinese government. The company's low beta of 0.03 may not fully capture the potential volatility of the Chinese e-commerce market. Furthermore, PDD's high profit margin may be subject to compression if competition intensifies or if the company experiences margin contraction.
Horizon. 1-3 yr $142.85 (analyst consensus (n=33)) — multiple re-rating thesis requires a catalyst. 5 yr $130.26 at ~6% CAGR — dividend + buyback compounding. 10 yr $166.27 if the moat survives secular pressure.
2. AU — AngloGold Ashanti plc · score 101
Gold · price $89.34 · 1Y $123.29 · 5Y $119.56 · 10Y $152.61
FCF $4.2b B · Rev +64.9% A · D/E 0.22 A- · P/E 13.1x B+ · PEG 0.78 A-
Why now. AngloGold Ashanti plc, a gold mining company selling to refineries and banks in the global gold market, is currently undervalued with a 13.1 P/E and a 0.78 PEG ratio, indicating a statistical cheapness. The company has a 64.9% revenue growth rate and a 31.1% profit margin, driven by its efficient operations and increasing gold prices. With an analyst consensus 1-yr target of $123.29, the stock has a potential re-rating catalyst.
Moat. AngloGold Ashanti's durable competitive advantage lies in its low-cost gold production, with a 43% ROE driven by its pricing power from category leadership in the gold mining industry. The company's 4 PS ratio indicates its ability to generate significant cash flow from its operations, which is then used to reduce debt and increase shareholder value. Additionally, its 0.22 debt-to-equity ratio provides a comfortable financial position to weather industry fluctuations.
Risk. The company faces risks from competitors such as Barrick Gold and Newmont Corporation, as well as regulatory risks from governments in countries where it operates, such as the South African Department of Mineral Resources. The 0.62 beta indicates a relatively low volatility, but the company's $4.2B FCF may be affected by fluctuations in gold prices. Furthermore, the 7 analyst consensus may not fully capture the company's potential risks and uncertainties.
Horizon. 1-3 yr $123.29 (analyst consensus (n=7)) — multiple re-rating thesis requires a catalyst. 5 yr $119.56 at ~6% CAGR — dividend + buyback compounding. 10 yr $152.61 if the moat survives secular pressure.
3. ADBE — Adobe Inc. · score 98
Software - Application · price $254.99 · 1Y $327.28 · 5Y $341.23 · 10Y $435.56
FCF $10.3b A- · Rev +12.0% B+ · D/E 0.58 B+ · P/E 14.9x B+ · PEG 0.73 A-
Why now. Adobe Inc., a leading provider of software applications, is currently trading at a $254.99 price point with a 14.9 P/E ratio, indicating potential undervaluation. The company's 12% revenue growth rate and 29.5% profit margin suggest a strong business foundation. With an analyst consensus 1-yr target of $327.28, there is a potential re-rating catalyst.
Moat. Adobe's durable competitive advantage stems from its category leadership in creative software applications, with products like Photoshop and Illustrator, resulting in a high 58.8% ROE. The company's pricing power, driven by its strong market share and customer loyalty, enables it to maintain high margins. Additionally, Adobe's software-as-a-service (SaaS) model provides a cost advantage and creates switching costs for customers.
Risk. The main risks for Adobe include competition from other software providers like Microsoft and Autodesk, regulatory scrutiny from agencies like the FTC, and potential disruptions to its creative cloud business. The company's 1.42 beta and 0.58 debt-to-equity ratio also pose risks. Furthermore, Adobe's reliance on its creative cloud business makes it vulnerable to changes in the creative software market.
Horizon. 1-3 yr $327.28 (analyst consensus (n=34)) — multiple re-rating thesis requires a catalyst. 5 yr $341.23 at ~6% CAGR — dividend + buyback compounding. 10 yr $435.56 if the moat survives secular pressure.
4. BZ — KANZHUN LIMITED · score 98
Internet Content & Information · price $14.11 · 1Y $21.67 · 5Y $18.88 · 10Y $24.10
FCF $652m C+ · Rev +14.0% B+ · D/E 0.01 A · P/E 16.2x B+ · PEG 0.16 A
Why now. KANZHUN LIMITED, an online education platform, is undervalued given its 14% revenue growth rate, 33.1% profit margin, and $21.67 analyst consensus 1-yr target. The company's low debt-to-equity ratio of 0.01 and high ROE of 15.4% also suggest a strong financial foundation. With a current price of $14.11, the stock has significant upside potential.
Moat. KANZHUN LIMITED's durable competitive advantage stems from its high 33.1% profit margin, which is driven by its strong position in the online education market. The company's 15.4% ROE is also a result of its ability to maintain pricing power, likely due to its category leadership in online education. Additionally, the company's low 0.01 debt-to-equity ratio provides a cost advantage, allowing it to invest in growth initiatives without taking on excessive debt.
Risk. The main risks facing KANZHUN LIMITED include intense competition from other online education platforms, regulatory risks from Chinese authorities, and the potential for 14% revenue growth to slow down. The company's 0.48 beta also suggests that it may be more volatile than the overall market. Furthermore, the 16.2 P/E ratio may be elevated, leaving the stock vulnerable to multiple compression if growth slows.
Horizon. 1-3 yr $21.67 (analyst consensus (n=21)) — multiple re-rating thesis requires a catalyst. 5 yr $18.88 at ~6% CAGR — dividend + buyback compounding. 10 yr $24.10 if the moat survives secular pressure.
5. INCY — Incyte Corporation · score 97
Biotechnology · price $95.60 · 1Y $108.50 · 5Y $127.93 · 10Y $163.30
FCF $1.4b C+ · Rev +20.9% A- · D/E 0.01 A · P/E 13.5x B+ · PEG 0.36 A
Why now. Incyte Corporation, a biotechnology company selling oncology and autoimmune treatments to hospitals and pharmacies, offers an attractive setup with a current price of $95.60, a P/E of 13.5, and a revenue growth rate of 20.9%. The company's profit margin of 26.7% and FCF of $1.42B demonstrate its ability to generate cash and invest in growth initiatives. With an analyst consensus 1-yr target of $108.50, the stock appears undervalued.
Moat. Incyte's durable competitive advantage stems from its 30.8% ROE, driven by pricing power from category leadership in oncology and autoimmune treatments. The company's low debt-to-equity ratio of 0.01 and high profit margin enable it to invest in research and development, further solidifying its market position. Incyte's beta of 0.8 indicates a relatively stable stock price, allowing investors to benefit from the company's growth without excessive volatility.
Risk. Key risks for Incyte include competition from established pharmaceutical companies, such as Pfizer and Merck, and regulatory scrutiny from the FDA. The company's debt-to-equity ratio of 0.01 is low, but any increase in debt could pose a risk. Additionally, Incyte's revenue growth rate of 20.9% may be challenging to sustain, and any deceleration could impact the stock price.
Horizon. 1-3 yr $108.50 (analyst consensus (n=22)) — multiple re-rating thesis requires a catalyst. 5 yr $127.93 at ~6% CAGR — dividend + buyback compounding. 10 yr $163.30 if the moat survives secular pressure.
Speculative — asymmetric upside
1. BILL — BILL Holdings, Inc. · score 87
Software - Application · price $37.75 · 1Y $55.14 · 5Y $75.93 · 10Y $197.58
FCF $327m C · Rev +13.5% B+ · D/E 0.50 B+ · P/S 2.3x A- · PEG 0.38 A
Why now. BILL Holdings, Inc., a software application company, is currently trading at $37.75 with a 13.5% revenue growth rate and a 0.38 PEG ratio, indicating a potential for high growth. The company has a $55.14 analyst consensus 1-yr target, driven by its increasing revenue and improving free cash flow of $326,606,000. BILL sells financial software to businesses, allowing them to streamline their financial operations and make data-driven decisions.
Moat. BILL's durable competitive advantage lies in its ability to provide a comprehensive financial platform to its customers, with a 2.3 price-to-sales ratio indicating a reasonable valuation. The company's software helps businesses manage their finances, invoices, and payments, creating a network effect that makes it difficult for customers to switch to competitors. Additionally, BILL's high free cash flow margin and low debt-to-equity ratio of 0.5 provide a cost advantage, allowing the company to invest in research and development and expand its customer base.
Risk. One of the major risks facing BILL is competition from established players in the financial software industry, such as Intuit and Xero. The company's 1.22 beta indicates a high level of volatility, and its 0% profit margin suggests that the company is still investing heavily in growth. Furthermore, the company's high revenue growth rate may be difficult to sustain, and any deceleration could negatively impact the stock price.
Horizon. 1-3 yr $55.14 (analyst consensus (n=21)) — catalyst-driven; binary events dominate. 5 yr $75.93 — requires the platform / technology to reach commercial scale. 10 yr $197.58 — return distribution heavily skewed.
2. OMC — Omnicom Group Inc. · score 86
Advertising Agencies · price $71.83 · 1Y $99.80 · 5Y $144.48 · 10Y $375.95
FCF $3.0b B · Rev +69.2% A · D/E 1.11 C+ · P/S 1.0x A- · PEG 15.97 D
Why now. Omnicom Group Inc., a leading advertising agency, is poised for growth driven by its 69.2% revenue growth rate and $2.99B in free cash flow, with a 15.97 PEG ratio indicating potential for long-term growth. As a spec name, OMC's high-risk, high-reward setup is underpinned by its ability to deliver high-quality advertising services to its clients across various end markets. With an analyst consensus 1-yr target of $99.80, OMC's current price of $71.83 presents an attractive entry point for investors willing to take on the associated risks.
Moat. Omnicom Group's durable competitive advantage lies in its ability to deliver integrated advertising services, with a 1 price-to-sales ratio indicating a relatively low valuation. The company's 2% ROE is driven by its cost advantages and unique distribution network, which enables it to maintain a strong market share in the advertising industry. Additionally, OMC's 0.3% profit margin suggests a focus on delivering high-quality services while maintaining a lean cost structure.
Risk. Omnicom Group faces material risks, including a 1.11 debt-to-equity ratio, which may limit its ability to invest in growth initiatives. Additionally, the company operates in a highly competitive industry, with competitors such as WPP and Interpublic Group, and is subject to regulatory risks, including potential changes to advertising regulations by the FTC. A 0.68 beta also indicates that OMC's stock price may be volatile, making it a higher-risk investment.
Horizon. 1-3 yr $99.80 (analyst consensus (n=10)) — catalyst-driven; binary events dominate. 5 yr $144.48 — requires the platform / technology to reach commercial scale. 10 yr $375.95 — return distribution heavily skewed.
3. CRC — California Resources Corporation · score 83
Oil & Gas E&P · price $62.47 · 1Y $80.91 · 5Y $125.65 · 10Y $326.96
FCF $778m C+ · Rev +6.7% C+ · D/E 0.47 B+ · P/S 1.6x A- · PEG 0.28 A
Why now. California Resources Corporation, an oil and gas exploration and production company, sells its products to refiners, marketers, and other purchasers, with a current price of $62.47 and a peg ratio of 0.28, indicating potential undervaluation. The company's revenue growth rate of 6.7% and analyst consensus 1yr target of $80.91 suggest a promising outlook. As a spec name, CRC's high-risk, high-reward setup is driven by its ability to generate $778 million in free cash flow over the past twelve months.
Moat. CRC's durable competitive advantage lies in its cost advantages, with a debt-to-equity ratio of 0.47, allowing for more flexibility in its operations. The company's profit margin of -13.4% is a concern, but its return on equity of -14.4% is influenced by the volatility of the oil and gas industry. CRC's unique distribution and regulatory protection in California contribute to its moat, with a beta of 0.96 indicating relatively low volatility compared to the market.
Risk. The main risks facing CRC include the volatility of the oil and gas industry, with competitors such as Chevron and ExxonMobil posing a threat. The company's debt-to-equity ratio of 0.47 is a concern, and regulatory changes by agencies such as the EPA could impact its operations. Additionally, the week 52 low of $41.13 indicates potential downside risk, and the company's ability to execute on its growth strategy is crucial to its success.
Horizon. 1-3 yr $80.91 (analyst consensus (n=11)) — catalyst-driven; binary events dominate. 5 yr $125.65 — requires the platform / technology to reach commercial scale. 10 yr $326.96 — return distribution heavily skewed.
4. JAZZ — Jazz Pharmaceuticals plc · score 83
Biotechnology · price $237.45 · 1Y $241.76 · 5Y $477.60 · 10Y $1,243
FCF $1.1b C+ · Rev +19.1% B+ · D/E 1.20 C+ · P/S 3.4x B · PEG 0.96 B+
Why now. Jazz Pharmaceuticals plc, a biotechnology company selling sleep and hematology/oncology products, is set up for growth driven by its 19.1% revenue growth rate and $1.14B in free cash flow, with a 0.96 PEG ratio indicating reasonable valuation. The company's products, such as those for narcolepsy and acute lymphoblastic leukemia, are sold to patients and healthcare providers, with a focus on the US and European markets. The growth rate is driven by the increasing demand for these specialty products and the company's ability to expand its portfolio through strategic acquisitions and internal development.
Moat. Jazz Pharmaceuticals' durable competitive advantage lies in its strong portfolio of specialty products, including Xyrem for narcolepsy and Erwinaze for acute lymphoblastic leukemia, with a 3.4 price-to-sales ratio indicating a premium valuation. The company's products have high switching costs, as patients often require ongoing treatment and are less likely to switch to alternative therapies. Additionally, Jazz Pharmaceuticals has a strong distribution network and regulatory protection, with orphan drug exclusivity for some of its products, contributing to its 0.7% return on equity.
Risk. The main risks facing Jazz Pharmaceuticals include competition from other biotechnology companies, such as Biogen and Gilead, and regulatory risks from agencies like the FDA and EMA. The company's 1.2 debt-to-equity ratio and 0.27 beta indicate a moderate level of financial and market risk. Additionally, the company's reliance on a few key products and its ability to maintain pricing power in a competitive market are key risks to its profitability and growth prospects.
Horizon. 1-3 yr $241.76 (analyst consensus (n=17)) — catalyst-driven; binary events dominate. 5 yr $477.60 — requires the platform / technology to reach commercial scale. 10 yr $1,243 — return distribution heavily skewed.
5. TEAM — Atlassian Corporation · score 83
Software - Application · price $86.62 · 1Y $143.18 · 5Y $174.22 · 10Y $453.35
FCF $1.2b C+ · Rev +31.7% A · D/E 1.41 C+ · P/S 3.6x B · PEG 0.68 A-
Why now. Atlassian Corporation, a software application company, currently trades at $86.62 with a 31.7% revenue growth rate and a 0.68 PEG ratio, indicating a high-growth setup. The company's $1.2B in free cash flow suggests a strong financial foundation. As a spec name, Atlassian's growth is driven by its cloud-based products, such as Jira and Confluence, which cater to a wide range of customers, from small businesses to large enterprises, in various end markets, including software development, IT, and business operations.
Moat. Atlassian's durable competitive advantage lies in its high-switching-cost products, such as Jira and Confluence, which have become essential tools for many businesses. The company's -19.3% ROE is a result of its significant investments in research and development, which have enabled it to maintain a strong market share in the software development and collaboration space. Additionally, Atlassian's products have a strong network effect, as more users and customers adopt its platforms, increasing their value and making it harder for competitors to gain traction.
Risk. Atlassian faces significant competition from other software companies, such as Microsoft and Salesforce, which could potentially disrupt its market share. The company's 1.41 debt-to-equity ratio and -3.5% profit margin also pose risks, as they may limit its ability to invest in new products and technologies. Furthermore, regulatory risks, such as changes in data protection laws, could impact Atlassian's ability to operate and grow its business.
Horizon. 1-3 yr $143.18 (analyst consensus (n=31)) — catalyst-driven; binary events dominate. 5 yr $174.22 — requires the platform / technology to reach commercial scale. 10 yr $453.35 — return distribution heavily skewed.
Methodology footnote
Every pick on this list comes out of the same seven-grade quantitative model applied to every US-listed common stock with a market cap above $1B. Each pick's score breakdown is auditable from the home page — click the ticker on the rankings page to see exactly which grades and adjustments produced the number. Not investment advice. See terms for full disclosures.